NIH-funded research R15 grant

Understanding how a specific protein affects cell junctions in epithelial tissues

Official title: Regulation of epithelial junctions stability and turnover by the RhoG exchange factor SGEF

Funded at University of Toledo · NIH-10974904 · Data updated 2026-11-12

This study is looking at how a protein called SGEF helps keep the connections between cells strong and stable, which is important for the health of tissues in our body, and it could help us understand more about conditions that affect these connections.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Toledo
NIH-funded
Lab location1 site (Toledo, United States)
Project startJuly 1, 2024
Project endJune 30, 2027
Funding year2024
Award (this year)$458,500
NIH project number1R15GM155874-01
Project IDNIH-10974904 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions related to epithelial cell dysfunction, including certain types of cancer or congenital abnormalities.

Less likely to help

Patients with conditions unrelated to epithelial cell adhesion or stability may not benefit from this research.

What this research studies

This research investigates the role of a protein called SGEF in maintaining the stability and turnover of cell junctions in epithelial cells. Epithelial cells are crucial for forming barriers in the body, and this study aims to uncover how SGEF interacts with other proteins to regulate these junctions. By using advanced techniques, the researchers will explore the molecular mechanisms behind cell adhesion and polarity, which are vital for proper tissue function. The findings could lead to better understanding of various conditions related to cell adhesion and tissue integrity.

Why it matters

Potential benefit: If successful, this research could lead to new insights into treating conditions related to epithelial dysfunction, such as certain cancers and birth defects.

How similar studies have gone: Other research has shown success in understanding cell junctions and their regulation, making this approach promising but still focused on a specific protein interaction.

Where this research is happening

  • University of Toledo
    Toledo, United States
    Active

Researchers

  • Principal investigator: Garcia-Mata, Rafael — University of Toledo
  • Study coordinator: Garcia-Mata, Rafael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.